- Home
- LGVN vs LSBPW Comparison
LGVN vs LSBPW Comparison
Compare LGVN & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- LSBPW
- Stock Information
- Founded
- LGVN 2014
- LSBPW N/A
- Country
- LGVN United States
- LSBPW China
- Employees
- LGVN N/A
- LSBPW 758
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- LSBPW Biotechnology: Pharmaceutical Preparations
- Sector
- LGVN Health Care
- LSBPW Health Care
- Exchange
- LGVN Nasdaq
- LSBPW Nasdaq
- Market Cap
- LGVN 30.0M
- LSBPW N/A
- IPO Year
- LGVN 2021
- LSBPW N/A
- Fundamental
- Price
- LGVN $2.05
- LSBPW $0.07
- Analyst Decision
- LGVN Strong Buy
- LSBPW
- Analyst Count
- LGVN 2
- LSBPW 0
- Target Price
- LGVN $8.00
- LSBPW N/A
- AVG Volume (30 Days)
- LGVN 393.9K
- LSBPW N/A
- Earning Date
- LGVN 11-08-2024
- LSBPW N/A
- Dividend Yield
- LGVN N/A
- LSBPW N/A
- EPS Growth
- LGVN N/A
- LSBPW N/A
- EPS
- LGVN N/A
- LSBPW N/A
- Revenue
- LGVN $1,229,000.00
- LSBPW N/A
- Revenue This Year
- LGVN $161.78
- LSBPW N/A
- Revenue Next Year
- LGVN $8.62
- LSBPW N/A
- P/E Ratio
- LGVN N/A
- LSBPW N/A
- Revenue Growth
- LGVN 39.34
- LSBPW N/A
- 52 Week Low
- LGVN $0.77
- LSBPW N/A
- 52 Week High
- LGVN $23.90
- LSBPW N/A
- Technical
- Relative Strength Index (RSI)
- LGVN 52.20
- LSBPW N/A
- Support Level
- LGVN $1.76
- LSBPW N/A
- Resistance Level
- LGVN $2.26
- LSBPW N/A
- Average True Range (ATR)
- LGVN 0.12
- LSBPW 0.00
- MACD
- LGVN 0.05
- LSBPW 0.00
- Stochastic Oscillator
- LGVN 58.00
- LSBPW 0.00
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About LSBPW LakeShore Biopharma Co. Ltd
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.